2025
The Role of the Interventional Radiologist in Stopping Bleeding in Cancer Patients
Fish A, Madoff D. The Role of the Interventional Radiologist in Stopping Bleeding in Cancer Patients. Current Oncology Reports 2025, 27: 483-489. PMID: 40120057, DOI: 10.1007/s11912-025-01663-5.Peer-Reviewed Original ResearchUterine artery embolizationBronchial artery embolizationArtery embolizationBronchial arterial chemoembolizationMalignancy-related bleedingLife-threatening complicationsImproved long-term controlMultidisciplinary approachLong-term controlTumor bleedingArterial chemoembolizationSuperselective embolizationIschemic complicationsEmbolization techniquesInterventional radiologistsControl hemorrhageLung cancerHemostatic solutionsCancer patientsEmbolizationEndovascular interventionStop bleedingImprove outcomesBleedingHemorrhage
2024
What Do Parents of My Patients Need to Know About Asthma and Its Management?
Tolomeo C. What Do Parents of My Patients Need to Know About Asthma and Its Management? 2024, 195-197. DOI: 10.1201/9781003523611-45.Peer-Reviewed Original Research
2019
Asthma in adults: Principles of treatment.
Kwah JH, Peters AT. Asthma in adults: Principles of treatment. Allergy & Asthma Proceedings 2019, 40: 396-402. PMID: 31690379, DOI: 10.2500/aap.2019.40.4256.Peer-Reviewed Original ResearchConceptsAllergen immunotherapyAllergic asthmaBetter long-term controlModerate allergic asthmaT2-high asthmaType 2 inflammationGastroesophageal reflux diseasePrevention of exacerbationsAllergen-specific immunotherapyEmergency department visitsPhysical examination findingsExpiratory flow rateGoal of treatmentPrinciples of treatmentReduction of symptomsSeverity of symptomsNormal activity levelsLong-term controlReflux diseaseSevere asthmaAllergic rhinitisAsthma symptomsBiologic therapyPulmonary functionSelect patients
2016
Immune Activation and HIV-Specific CD8+ T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers
Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin BE, Ferre AL, Gillespie GM, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich SS, Shacklett BL. Immune Activation and HIV-Specific CD8+ T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. AIDS Research And Human Retroviruses 2016, 32: 791-800. PMID: 27019338, PMCID: PMC4971411, DOI: 10.1089/aid.2015.0313.Peer-Reviewed Original ResearchMeSH KeywordsADP-ribosyl Cyclase 1Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCD8-Positive T-LymphocytesDisease ResistanceGene ExpressionHIV InfectionsHIV-1HLA-DR AntigensHost-Pathogen InteractionsHumansLeukocyte Common AntigensLymphocyte ActivationReceptors, CCR5Receptors, CCR7RNA, ViralViral LoadViremiaConceptsCentral nervous systemHIV controllersAntiretroviral therapyT cellsCerebrospinal fluidViral loadCopies/HIV-specific T cellsMajor histocompatibility complex class IActivation markers CD38CSF viral loadHIV-specific CD8Undetectable plasma viremiaExpression of CCR5Majority of HIVPlasma viral loadEffector memory cellsHIV-negative controlsHistocompatibility complex class IAbsence of therapyComplex class ILong-term controlPlasma viremiaElite controllersHIV infection
2015
Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
Tall H, Yaro S, Kpoda H, Ouangraoua S, Trotter C, Lafourcade B, Findlow H, Bai X, Martin C, Nwakamma I, Ouedraogo J, Gessner B, Borrow R, Mueller J. Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso. Clinical Infectious Diseases 2015, 61: s540-s546. PMID: 26553686, PMCID: PMC4639492, DOI: 10.1093/cid/civ519.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnimalsAntibodies, BacterialBlood Bactericidal ActivityBurkina FasoChildChild, PreschoolComplement System ProteinsFemaleHumansImmunoglobulin GInfantMaleMass VaccinationMeningitis, MeningococcalMeningococcal VaccinesNeisseria meningitidis, Serogroup ARabbitsSeroepidemiologic StudiesYoung AdultConceptsAntibody titersSerum bactericidal antibody titersVaccine-eligible age groupsBactericidal antibody titersGeometric mean titersAfrican meningitis beltPopulation-level immunitySpecific antibody titersMass immunization campaignOptimal vaccination strategyImmunoglobulin G concentrationLong-term controlPsA-TTMean titersVaccine coverageProtective antibodiesMeningitis beltBlood drawVaccination strategiesImmunization campaignRabbit complementGroup AHigh seroprevalenceStandardized interviewAge groups
2012
The promise and pitfalls of mass drug administration to control intestinal helminth infections
Humphries D, Nguyen S, Boakye D, Wilson M, Cappello M. The promise and pitfalls of mass drug administration to control intestinal helminth infections. Current Opinion In Infectious Diseases 2012, 25: 584-589. PMID: 22903231, DOI: 10.1097/qco.0b013e328357e4cf.Peer-Reviewed Original ResearchConceptsMass drug administrationIntestinal helminth infectionsHelminth infectionsDrug AdministrationSoil-transmitted nematode infectionsIntensity of schistosomiasisHigh-risk groupResource-limited settingsLong-term controlSignificant morbidityPregnant womenLong-term benefitsNew drug developmentIntensity of infectionIntestinal helminthsEndemic areasConsistent benefitInfectionChemotherapeutic interventionCertain populationsDrug developmentBenzimidazole anthelminthicsIntensive monitoringPrevalenceAdministration
2003
Activating and inactivating mutations of the human mineralocorticoid receptor
Geller D. Activating and inactivating mutations of the human mineralocorticoid receptor. Current Opinion In Endocrinology Diabetes And Obesity 2003, 10: 186-190. DOI: 10.1097/00060793-200306000-00005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsBlood pressureRenal sodium reabsorptionPrincipal effector moleculeNet sodium balanceLong-term controlAldosterone systemSodium reabsorptionMineralocorticoid receptorSodium balanceDistal nephronCardiovascular physiologyEffector moleculesFunction mutationsKidneyReceptorsHuman diseasesPhysiologyNumerous linesMutationsDiseaseNephronFine regulationReabsorption
1999
Minimally Invasive Surgical Techniques for the Treatment of Gastroesophageal Reflux Disease
Klingler P, Bammer T, Wetscher G, Glaser K, Seelig M, Floch N, Branton S, Hinder R. Minimally Invasive Surgical Techniques for the Treatment of Gastroesophageal Reflux Disease. Digestive Diseases 1999, 17: 23-36. PMID: 10436354, DOI: 10.1159/000016900.Peer-Reviewed Original ResearchConceptsGastroesophageal reflux diseaseReflux diseaseAntireflux surgeryAntireflux procedureIntroduction of minimally invasive techniquesTreatment of gastroesophageal reflux diseaseIntroduction of minimally invasive surgeryMinimally invasive surgical techniquesYears of follow-upLaparoscopic antireflux proceduresPoor surgical resultsManagement of gastroesophageal reflux diseaseMinimally invasive techniquesInvasive surgical techniquesSurgical management of gastroesophageal reflux diseaseMinimally invasive surgeryLong-term controlSurgical resultsInappropriate surgerySurgical managementInexperienced surgeonsSurgical techniqueInvasive techniquesFollow-upSurgery
1998
Laparoskopische Antirefluxverfahren
Klingler P, Hinder R, Smith S, Branton S, Floch N, Seelig M. Laparoskopische Antirefluxverfahren. Die Chirurgie 1998, 69: 148-157. PMID: 9551258, DOI: 10.1007/s001040050389.Peer-Reviewed Original ResearchConceptsMedically refractory gastroesophageal reflux diseaseLong-term control of symptomsSide effectsRefractory gastroesophageal reflux diseaseLaparoscopic antireflux surgeryPermanent side effectsGastroesophageal reflux diseaseControl of symptomsFollow-up dataLong-term controlAntireflux surgeryReflux disease
1987
Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
Dawson DM, Carter JL, Hafler DA, Weiner HL. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Nuova Rivista Di Neurologia 1987, 57: 88-91. PMID: 3039645.Peer-Reviewed Original ResearchConceptsProgressive multiple sclerosisMonoclonal antibody therapyMultiple sclerosisAntibody therapyChronic progressive multiple sclerosisHigh-dose intravenous cyclophosphamideMultiple sclerosis patientsForm of treatmentLong-term controlIntravenous cyclophosphamideSclerosis patientsClinical resultsSerious toxicityImmune parametersPilot trialCyclophosphamideNervous systemSclerosisTerm controlsPatientsMonoclonal antibodiesACTHOnly small numbersTherapyAdverse effects
1980
Use of Selective Arteriography in the Treatment of Epistaxis
Rosnagle R, Allen W, Kier E, Rothman S. Use of Selective Arteriography in the Treatment of Epistaxis. JAMA Otolaryngology - Head & Neck Surgery 1980, 106: 137-142. PMID: 7356432, DOI: 10.1001/archotol.1980.00790270001001.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply